Better Coronavirus Stock: Inovio Pharmaceuticals or VBI Vaccines?
The COVID-19 pandemic has drastically changed the trajectory for two small biotechs. Inovio Pharmaceuticals (NASDAQ: INO) is enjoying its best stock performance in seven years thanks to investors' interest in its novel coronavirus vaccine program. VBI Vaccines (NASDAQ: VBIV) appears to be on track for its best year ever -- for the same reason.
But which of these coronavirus stocks is the better pick right now? Here's how Inovio and VBI compare.
Image source: Getty Images.
Source Fool.com
